Therapeutics

Our team is passionate about identifying transformational science that can provide meaningful benefit to patients' lives. Using a diverse combination of scientific, operational and business expertise, we work closely with scientists and entrepreneurs to create and build companies that enable rapid development of science into commercial reality. 

See the Therapeutics portfolio

Apple Tree Partners Team

Venture Partners, Entrepreneurs-in-Residence, and Advisors

Medical Devices

We invest in therapeutic medical device technologies that can dramatically improve the human condition by providing better and more predictable outcomes, reducing a patient’s dependence on medication and improving healthcare efficiency while reducing costs.  Our team partners with experienced entrepreneurs to fund innovation across the continuum from the earliest stages of concept development to revenue-stage companies seeking growth capital.  We bring substantial clinical and operational expertise in the medical device industry to our portfolio companies, helping to guide them through all stages of growth.

See the Medical Devices portfolio

Healthcare Services

We are committed to building market-leading companies that have the potential to fundamentally transform the way healthcare is delivered, improving lives of patients and providers. Our deep investing and operational expertise enables us to work closely with management teams toward this aim.

See the Healthcare Services portfolio

Finance & Administration

Apple Tree Partners Team

Apple Tree Partners

Apple Tree Partners (ATP) is a a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services. Founded in 1999, with a history of well-known successes, we closed our current capital pool of $1.5 billion in 2012 and are actively funding healthcare innovation.

We start companies, or invest in existing companies, with commitments as high as $250 million; in this sense, we scale to the buy-out or growth equity level. But we take the long view, both as a matter of principle and for value creation. An ATP company may choose to sell in an M&A transaction, but only if the price is right, or may access the public markets, but only if advantageous to do so. This means our managers can build with confidence, knowing that we are funding them to grow and develop their businesses.

We are headquartered in New York City, with additional offices in Cambridge, MA, and Los Altos, CA.